6533b831fe1ef96bd12994e8

RESEARCH PRODUCT

A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates

V. M. StoneM. M. HankaniemiO. H. LaitinenA. B. Sioofy-khojineA. LinI. M. Diaz LozanoM. A. MazurV. MarjomäkiK. LoréH. HyötyV. P. HytönenM. Flodström-tullberg

subject

PrimatesImmunologynuoruustyypin diabetesrokotteetvasta-aineetSciAdv r-articlesCoxsackievirus Infectionscomplex mixturesEnterovirus B HumanenteroviruksetMiceMyocarditisVirologyAnimalsimmuniteettiHealth and MedicineVaccines Combinedkoe-eläinmallitResearch ArticlesResearch Article

description

A proof-of-concept study shows the generation of an immunogenic hexavalent Coxsackie B virus vaccine that prevents disease.

http://urn.fi/URN:NBN:fi:jyu-202005183263